Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

bioMerieux

Founders Alain Mu00e9rieux

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 7
Rounds per year 0.12
Lead investments 1
Exits 2
Key employees 2

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Life Science
  • Health Diagnostics
Summary

bioMerieux is the famous Corporate Investor, which was founded in 1963. The fund was located in Europe if to be more exact in France. The leading representative office of defined Corporate Investor is situated in the Marcy-l'etoile.

The usual cause for the fund is to invest in rounds with 4 partakers. Despite the bioMerieux, startups are often financed by Whitecap Venture Partners, SLS Venture, LD Pensions. The meaningful sponsors for the fund in investment in the same round are Whitecap Venture Partners, Societe Generale Asset Management, Sands Capital Ventures. In the next rounds fund is usually obtained by SLS Venture, LD Pensions, Tufts University.

Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. When the investment is from bioMerieux the average startup value is 10-50 millions dollars. This bioMerieux works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2017. The important activity for fund was in 2007.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AdvanDx, Qvella Corporation, Quanterix. Among the most successful fund investment fields, there are Life Science, Hospital. The fund has exact preference in some founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of bioMerieux:
Typical Co-investors
bioMerieux is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after bioMerieux:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aisidi China, Guangdong, Shenzhen
Audi AG Bayern, Germany, Ingolstadt
Fanchuang Capital Beijing, Beijing, China
Huami Beijing, Beijing, China
Periscope Equity Chicago, Illinois, United States
Robotic Ventures LLC -
Shanghai Hongli Guquan Touzi Co., Ltd. China, Shanghai
Zhejiang Chuangxin Chanye Touzi China, Hangzhou, Zhejiang
Zhongji Chuangtou -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

InDevR

Biotechnology
Health Care
Life Science
Manufacturing
$9M17 Jan 2023 Boulder, Colorado, United States

accunome

23 Dec 2022 Nanhu District, Zhejiang, China

Biotechnology
Data Center Automation
$9M11 Jun 2020 Jerusalem, Jerusalem District, Israel

Qvella Corporation

Biotechnology
Health Diagnostics
Medical Device
$20M04 Dec 2017 Richmond Hill, Ontario, Canada

Quanterix

Analytics
Biotechnology
Health Diagnostics
Life Science
Pharmaceutical
$18M15 Nov 2012 Massachusetts, United States

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$15M18 Sep 2007 Woburn, Massachusetts, United States

MEDoctor

Health Care
Home Health Care
$3M01 Aug 2000 Wilmington, Delaware, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent bioMerieux?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: